Xie Jian 4

What Happened Jian Xie, President and COO of Fulgent Genetics (FLGT), had a total of 10,366 shares withheld to satisfy tax-withholding obligations when restricted stock units (RSUs) vested. The withholding transactions — reported on a Form 4 filed March 2, 2026 (period of report Feb 26, 2026) — resulted in gross proceeds (value withheld) of about $169,661 across three events. The transactions were coded F (tax withholding), meaning shares were not sold in an open-market trade but retained/withheld to cover taxes on RSU vesting.

Key Details

• Transactions:
  • 2026-02-26: 1,140 shares withheld @ $24.76 = $28,226 (F)
  • 2026-03-01: 1,079 shares withheld @ $15.33 = $16,541 (F)
  • 2026-03-01: 8,147 shares withheld @ $15.33 = $124,894 (F)
  • Total withheld: 10,366 shares; aggregate value ≈ $169,661.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: Withholdings tied to vesting of RSUs granted on Feb 28, 2022 (F2), Feb 26, 2024 (F1), and Feb 25, 2025 (F3). Footnote F4 notes securities held by The Hsieh Family Dynasty Trust; Mr. Xie serves on the trust’s investment committee and disclaims beneficial interest except any pecuniary interest.
• Timeliness: Form 4 was filed March 2, 2026. The filing shows no late-report indication.

Context

• Transaction code F = tax withholding for vested awards. This is a routine administrative step to satisfy taxes when RSUs vest, not an open-market sale intended to realize gains or express a view on the stock.
• Such withholdings are common for executives and generally don’t imply a change in insider sentiment; purchases are typically a stronger signal of insider conviction.